Su-Ying Liang, PhD

Primary care physicians who address multiple problems during acute care visits achieve better clinical scores, comparable patient experience, and lower annual cost.

Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.